CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide von Madhumathi, Jayaprakasam, Sridevi, Surapally, Verma, Rama Shanker

Volltext

Curcumin augments therapeutic efficacy of TRAIL-based immunotoxins in leukemia von Surapally, Sridevi, Jayaprakasam, Madhumathi, Verma, Rama Shanker

Volltext

Emerging therapies for inv(16) AML von Surapally, Sridevi, Tenen, Daniel G., Pulikkan, John A.

Volltext

Differential Engraftment of CEBPA Mutated Acute Myeloid Leukemia Cells in NSGS Mice von Peramangalam, Philomina Sona, Surapally, Sridevi, Rao, Sridhar, Müller-Tidow, Carsten, Pulikkan, John Anto

Volltext

MYCN Regulates Cell Survival Via EIF4G1 in Inv(16) Acute Myeloid Leukemia von Peramangalam, Philomina Sona, Surapally, Sridevi, Zheng, Shikan, Burns, Robert, Zhu, Nan, Rao, Sridhar, Müller-Tidow, Carsten, Pulikkan, John Anto

Volltext

Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia von Madhumathi, Jayaprakasam, Sridevi, Surapally, Verma, Rama Shanker

Volltext

Immunotoxin therapy for hematologic malignancies: where are we heading? von Madhumathi, Jayaprakasam, Devilakshmi, Sithambaram, Sridevi, Surapally, Verma, Rama S.

Volltext

Immunotoxin therapy for hematologic malignancies: where are we heading?: Post screen von Madhumathi, Jayaprakasam, Devilakshmi, Sithambaram, Sridevi, Surapally, Verma, Rama S

Volltext

N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia von Peramangalam, Philomina Sona, Surapally, Sridevi, Veltri, Anthony J, Zheng, Shikan, Burns, Robert, Zhu, Nan, Rao, Sridhar, Muller-Tidow, Carsten, Bushweller, John H, Pulikkan, John A

Volltext